相似文献
1
Dissolution of gall stones with an ursodeoxycholic acid menthol preparation: a controlled prospective double blind trial.
Gut. 1988 Apr;29(4):428-32. doi: 10.1136/gut.29.4.428.
2
Ursodeoxycholic acid for the dissolution of radiolucent gall bladder stones.
Digestion. 1983;28(4):225-33. doi: 10.1159/000198992.
3
Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses.
J Int Med Res. 1982;10(1):59-63. doi: 10.1177/030006058201000112.
4
Combination therapy with oral ursodeoxycholic and chenodeoxycholic acids: pretreatment computed tomography of the gall bladder improves gall stone dissolution efficacy.
Gut. 1992 Mar;33(3):375-80. doi: 10.1136/gut.33.3.375.
5
6
Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.
Gut. 1993 Sep;34(9):1277-88. doi: 10.1136/gut.34.9.1277.
7
Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Gastroenterology. 1983 Dec;85(6):1257-64.
8
[Treatment of cholesterol gallstones with ursodesoxycholic acid (author's transl)].
Nouv Presse Med. 1982 Feb 20;11(8):587-9.
9
Optimum bile acid treatment for rapid gall stone dissolution.
Gut. 1992 Mar;33(3):381-6. doi: 10.1136/gut.33.3.381.
10
Gall stone dissolving agents.
Br Med J (Clin Res Ed). 1983 Mar 5;286(6367):778-80. doi: 10.1136/bmj.286.6367.778.
引用本文的文献
1
Combinatorial Effects of Terpene, Chenodeoxycholic Acid, and Ursodeoxycholic Acid on Common Bile Duct Stone Recurrence and Gallbladder Stone Dissolution.
J Clin Med. 2024 Dec 5;13(23):7414. doi: 10.3390/jcm13237414.
2
Effect of Rowachol on the Gallbladder Dysmotility Disorder Based on Gallbladder Ejection Fraction.
Medicina (Kaunas). 2023 Jan 3;59(1):105. doi: 10.3390/medicina59010105.
3
Evidence-based clinical practice guidelines for cholelithiasis 2016.
J Gastroenterol. 2017 Mar;52(3):276-300. doi: 10.1007/s00535-016-1289-7. Epub 2016 Dec 10.
本文引用的文献
1
Enzymatic cleavage of conjugated glucuronic acids in relation to the problem of mineralysis.
Enzymologia. 1951 Nov;15(3):115-21.
2
Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.
Gastroenterology. 1980 Jun;78(6):1412-8.
3
Gallstone dissolution after 6 months of ursodeoxycholic acid (UDCA): effectiveness of different doses.
J Int Med Res. 1982;10(1):59-63. doi: 10.1177/030006058201000112.
4
Treatment of biliary duct stones with a terpene preparation.
Br Med J (Clin Res Ed). 1981 Feb 21;282(6264):611. doi: 10.1136/bmj.282.6264.611.
5
Franco-Belgian cooperative study of ursodeoxycholic acid in the medical dissolution of gallstones: a double-blind, randomized, dose-response study, and comparison with chenodeoxycholic acid.
Hepatology. 1984 Mar-Apr;4(2):308-14. doi: 10.1002/hep.1840040222.
6
Pilot study of combination treatment for gall stones with medium dose chenodeoxycholic acid and a terpene preparation.
Br Med J (Clin Res Ed). 1984 Jul 21;289(6438):153-6. doi: 10.1136/bmj.289.6438.153.
7
Is recurrence inevitable after gallstone dissolution by bile-acid treatment?
Lancet. 1982 Jan 23;1(8265):181-5. doi: 10.1016/s0140-6736(82)90757-7.
8
Stones in the common bile duct: experience with medical dissolution therapy.
Postgrad Med J. 1985 Apr;61(714):313-6. doi: 10.1136/pgmj.61.714.313.
9
Chenodeoxycholic acid treatment of gallstones. A follow-up report and analysis of factors influencing response to therapy.
N Engl J Med. 1975 Aug 21;293(8):378-83. doi: 10.1056/NEJM197508212930804.
10
Effect of d-limonene and related compounds on bile flow and biliary lipid composition in rats and dogs.
Life Sci. 1976 Nov 15;19(10):1559-67. doi: 10.1016/0024-3205(76)90102-8.
Zotero 插件